You are here: Home > Institute of Excellence (CPD) > CPD Events > SS3L1 Diabetic Eye Disease

SS3L1 Diabetic Eye Disease

Date: 18/06/2019

Venue: ACO, 374 Cardigan St, Carlton, VIC, 3165

Provider: Australian College of Optometry

Contact: Liz Salvatore, [E], [P] 03 9349 7477

Learning Objectives

  • Explain the factors that should be considered when deciding to initiate treatment in a patient who has been recently diagnosed with diabetic retinopathy (DR)
  • Discuss the rationale for the selection of a particular pharmacologic agent when managing a case of proliferative diabetic retinopathy
  • Outline the alternatives for DR patients who do not respond adequately to anti-VEGF drugs
  • Discuss the current research and future development of more potent pharmacologic agents for the management of DR

Max points awarded: 3.00

Session Information

SS2L1 Diabetic Eye Disease
Activity Type
Face to Face with Assessment
Points for attending & Passing Assessment

NameActivity TypeTherapeutic?Manufacturer/
Points for attending &
Passing Assessment
SS2L1 Diabetic Eye DiseaseFace to Face with AssessmentNoNo3.00